Scientists are refining electroporation methods to improve CRISPR/Cas9 gene editing efficiency while preserving cell health. By adjusting buffer composition, pulse parameters, and delivery formats, ...

HOW EASILY could a malicious person with no scientific expertise and an axe to grind create and spread a nasty pathogen? The bar is constantly being lowered. Advances in genetic sequencing have made ...

Is PGEN a good stock to buy? We came across a bullish thesis on Precigen, Inc. on Valueinvestorsclub.com by coalone. In this ...

IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...

A Career Built on Care and Consistency Andrew Kaiser of Quincy has spent more than four decades working as a veterinarian.

Colossal Biosciences, the world's first de-extinction company, announces the bluebuck as the sixth species in its ...

Here, we report that glycolysis controls astrocyte-synapse contact. In the Drosophila larval dopaminergic (DAergic) circuit, blocking astrocyte glycolysis stimulated perisynaptic ensheathment by ...

A year after Baby KJ became the first person to receive a personalized CRISPR base-editing therapy for a lethal genetic disorder, he is thriving and has avoided a liver transplant. His case, enabled ...

Colossal Biosciences, the world's first de-extinction company, today announced the bluebuck ( Hippotragus leucophaeus) as the sixth species in its de-extinction portfolio. Hunted to extinction for its ...

High-content screening combines automated microscopy and quantitative image analysis to measure complex cellular phenotypes ...